Neurofit (380550) has 4 disclosed insider purchases and 0 disclosed disposals on record, filed by 2 distinct insiders. Together those filings cover ₩43M ($30K) in reported transaction value. The earliest filing StockDrifts holds for Neurofit is dated 2025-07-25; the most recent is 2026-05-29. Across these filings the average return since disclosure is -8.56%, measured from each filing date to the latest available close.
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | BUY | Market Buy | 빈준길 Binjungil | Co-CEO | 762 | ₩14,480 | -8.6% | ₩11M ($8K) |
| 2026-05-29 | BUY | Market Buy | 김동현 Donghyun Kim | Co-CEO | 1.0K | ₩14,480 | -8.6% | ₩14M ($10K) |
| 2026-05-29 | BUY | Market Buy | 빈준길 Binjungil | Co-CEO | 238 | ₩14,480 | -8.6% | ₩3M ($2K) |
| 2026-05-29 | BUY | Market Buy | 빈준길 Binjungil | Co-CEO | 1.0K | ₩14,480 | -8.6% | ₩14M ($10K) |
| 2026-04-30 | BUY | 주식매수선택권 | 김창일 Kim Chang-il | vice president | 21.3K | ₩20,100 | +0.0% | ₩428M ($297K) |
| 2025-10-17 | BUY | 주식매수선택권 | 임현국 Lim Hyeon-guk | Managing Director | 29.6K | ₩21,000 | +39.3% | ₩622M ($432K) |
| 2025-10-17 | BUY | 주식매수선택권 | 임현국 Lim Hyeon-guk | Managing Director | 14.6K | ₩21,000 | +39.3% | ₩307M ($214K) |
| 2025-08-12 | BUY | 주식매수선택권 | 임현국 Lim Hyeon-guk | Managing Director | 15.0K | ₩14,990 | +95.1% | ₩225M ($156K) |
| 2025-07-25 | BUY | 신규상장 | 빈준길 Binjungil | Co-CEO | 1.2M | ₩20,300 | +44.1% | ₩24.1B ($16.7M) |
| 2025-07-25 | BUY | 신규상장 | 김동현 Donghyun Kim | Co-CEO | 1.8M | ₩20,300 | +44.1% | ₩36.1B ($25.1M) |
Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.